(IN BRIEF) Novo Nordisk has announced promising headline results from the kidney outcomes trial FLOW, which compared injectable semaglutide 1.0…
(IN BRIEF) Deutsche Telekom, a leading telecommunications company, has expanded its involvement in blockchain technology by becoming a validator on…
LONDON, 10-Feb-2017 — /EuropaWire/ — Flow customers will now have even more access to international news with the addition of the…